Subscribe To
Aptose biosciences continues to drift without thesis-changing data
Aptose has made some progress in the clinic this year, including additional complete responses for lead program HM43239 and a new ...
July 19, 2022, 6:31 pm
Victoria's secret's latest perfume changes scent based on the person wearing it
Victoria's Secret & Co. VSCO, +3.40% introduced its latest fragrance, Bare Eau de Parfum, on Monday, a perfume that changes scent based on the body ch...
July 18, 2022, 10:18 am
Avicanna touts the national basketball players association selecting re+play as an official partner
Avicanna Inc revealed that the National Basketball Players Association (NBPA) has announced a new multi-year partnership with Re+Play, the performance...
July 13, 2022, 1:23 pm
Directa plus signs €150,000 supply agreement for its graphene nanoplatelets technology
Directa Plus PLC (AIM:DCTA, OTC:DTPKF) signed a supply agreement with Officine di Cartigliano for its patented G+ pristine graphene nanoplatelets t...
July 5, 2022, 2:52 am
Nuformix hoping to develop a 'bio-better' version of astrazeneca blockbuster
Nuformix PLC (LSE:NFX) is developing a pre-clinical programme to further assess the potential of NXP004, a re...
June 29, 2022, 2:54 am
Xphyto therapeutics says pharmaceutical manufacturing expert dr florian a. sahr has joined its european operations as project management head
XPhyto Therapeutics Corp has announced that Dr Florian A. Sahr, a German-born and internationally-trained leader in drug ...
June 8, 2022, 6:40 am
Ortho regenerative technologies is at the forefront of regenerative medicine with its elegantly simple tissue repair technology
Ortho Regenerative Technologies Inc (CSE:ORTH) is developing novel tissue repair therapies with the goal of dramatically increasing the success rates ...
June 3, 2022, 8:15 am
Outlook therapeutics opts to resubmit bla for wet amd drug after fda requests more info
Outlook Therapeutics (NASDAQ:OTLK) Inc said it has voluntarily withdrawn the biologics license application (BLA) for its ophthalmic ...
May 31, 2022, 10:26 am
Fsd pharma submits ind applications to the fda and health canada for phase 2 clinical trial of fsd-201 to treat an inflammatory disorder
FSD Pharma (CSE:HUGE, NASDAQ:HUGE) Inc has announced that it has submitted Investigation New Drug applications to the US Food and Drug Administration...
May 31, 2022, 10:26 am
Siga technologies: solid business with means to address monkeypox outbreak
SIGA Technologies' share price has been soaring as a result of approval for its IV smallpox therapy. The company's TPOXX ...
May 27, 2022, 12:22 pm
Cardiol therapeutics receives us fda authorization for phase ii study of cardiolrx for recurrent pericarditis
Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc announced that the US Food and Drug Administration has authorized its Investigational New Drug Applic...
May 17, 2022, 10:07 am
Skye bioscience says study shows enhanced reduction in intraocular pressure with its sbi-100 formulation for glaucoma
Skye Bioscience inc (OTCQB:SKYE) announced that the peer-reviewed journal International Journal of Pharmaceutics has published preclinical data demons...
May 5, 2022, 8:43 am
Mgc pharmaceuticals enters indian market through tie-up with hempstreet
MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has announced a partnership with HempStreet, India's first research to retail venture in the med...
May 4, 2022, 3:13 am
Why first wave biopharma shares are tanking today
First Wave BioPharma Inc (NASDAQ: FWBI) shares are plummeting after the company reported topline data from Phase 2 RESERVOIR trial of FW-COV, oral ...
May 2, 2022, 8:05 am
Gamida cell shares jump on fda nod to cell therapy trial in blood cancer settings
The FDA has signed off and removed the clinical hold for a cryopreserved formulation of Gamida Cell ...
April 26, 2022, 9:33 am
Fda gives green signal to human trial for sorrento's sti-9167 against omicron
The FDA has cleared Sorrento Therapeutics Inc's (NASDAQ: SRNE) investigational new drug application (IND) for intravenous (IV) STI-9167 (COVISHIEL...
April 25, 2022, 4:15 pm
Matinas (mtnb) up on deal with biontech for mrna vaccines
Matinas BioPharma (MTNB) forms an exclusive partnership with BioNTech (BNTX) to develop and advance novel form...
April 12, 2022, 4:33 pm
International flavors (iff) closes health wright products buyout
International Flavors' (IFF) latest buyout provides formulation and finished format capabilities to Hea...
April 5, 2022, 1:33 pm
Roche (rhhby) actemra application receives priority review
Roche (RHHBY) sBLA is seeking approval for the intravenous formulation of arthritis drug Actemra accept...
April 5, 2022, 1:33 pm
Nuformix says patent application for reformulated astrazeneca blockbuster has progressed to publication phase
Nuformix PLC (LSE:NFX) said its patent application for key asset NXP004 had progressed to the publication phase. Following this, it was able to reveal...
March 28, 2022, 2:56 am